Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin.

J Cancer · 2016 · PMC4911882 · PMID 27326258

Europe PMC DOI

hedged sentence

0.2300

closest p · 4.6× alpha

0.2300

boldest claim

The sentences

a statistical trendp=0.23not close (p > 0.1)

While 2uM of sorafenib alone didn't affect viability, the addition of Metformin resulted in statistically significant reduction in viability of SK-Hep-1 (p=0.029), and a statistical trend in reduction of viability in PLC/PRF/5 and HuH-7 (p=0.23, p=0.059 respectively; Fig. 1 ).

also in 1,557 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.